Julien Kirchgesner

Visiting researcher
Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France, France

Roche (Consultant/Advisory Board)

Poster(s):

• (P-002) Risk of First Ischemic Stroke and Use of Antidopaminergic Antiemetics: A Case-time-control Study in France